These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 15240927

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The clinical value of serum triiodothyronine, thyroxine and thyrotropin estimations during medical antithyroid treatment.
    Rogowski P, Friis T, Kirkegaard C, Siersbaek-Nielsen K.
    Acta Med Scand; 1977; 202(1-2):93-6. PubMed ID: 70965
    [Abstract] [Full Text] [Related]

  • 24. Bone turnover in overt and subclinical hyperthyroidism due to autonomous thyroid adenoma.
    De Menis E, Da Rin G, Roiter I, Legovini P, Foscolo G, Conte N.
    Horm Res; 1992; 37(6):217-20. PubMed ID: 1292974
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Serum osteocalcin in patients taking L-thyroxine who have subclinical hyperthyroidism.
    Ross DS, Ardisson LJ, Nussbaum SR, Meskell MJ.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):507-9. PubMed ID: 1991818
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Serum cytokines in thyrotoxicosis.
    Siddiqi A, Monson JP, Wood DF, Besser GM, Burrin JM.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):435-9. PubMed ID: 10022397
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Evaluation of thyroid-stimulating hormone, total thyroxine, and free thyroxine concentrations in hyperthyroid cats receiving methimazole treatment.
    Aldridge C, Behrend EN, Martin LG, Refsal K, Kemppainen RJ, Lee HP, Chciuk K.
    J Vet Intern Med; 2015 Feb; 29(3):862-8. PubMed ID: 25832129
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Plasma levels of resistin and ghrelin before and after treatment in patients with hyperthyroidism.
    El Gawad SS, El Kenawy F, Mousa AA, Omar AA.
    Endocr Pract; 2012 Feb; 18(3):376-81. PubMed ID: 21742599
    [Abstract] [Full Text] [Related]

  • 35. Biochemical markers of bone turnover in patients with thyroid dysfunctions and in euthyroid controls: a cross-sectional study.
    Engler H, Oettli RE, Riesen WF.
    Clin Chim Acta; 1999 Nov; 289(1-2):159-72. PubMed ID: 10556662
    [Abstract] [Full Text] [Related]

  • 36. Circulating Levels of Orexin-A, Nesfatin-1, Agouti-Related Peptide, and Neuropeptide Y in Patients with Hyperthyroidism.
    Tohma Y, Akturk M, Altinova A, Yassibas E, Cerit ET, Gulbahar O, Arslan M, Sanlier N, Toruner F.
    Thyroid; 2015 Jul; 25(7):776-83. PubMed ID: 25915725
    [Abstract] [Full Text] [Related]

  • 37. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
    Yavuz DG, Yüksel M, Deyneli O, Ozen Y, Aydin H, Akalin S.
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886
    [Abstract] [Full Text] [Related]

  • 38. Sclerostin and bone metabolism markers in hyperthyroidism before treatment and interrelations between them.
    Sarıtekin İ, Açıkgöz Ş, Bayraktaroğlu T, Kuzu F, Can M, Güven B, Mungan G, Büyükuysal Ç, Sarıkaya S.
    Acta Biochim Pol; 2017 Oct; 64(4):597-602. PubMed ID: 29059259
    [Abstract] [Full Text] [Related]

  • 39. [Osteocalcin and hyperthyroidism].
    Pandolfi C, Montanari G, Mercantini F, Sbalzarini G.
    Minerva Endocrinol; 1992 Oct; 17(2):75-8. PubMed ID: 1296147
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.